A

Akoya Biosciences Inc
NASDAQ:AKYA

Watchlist Manager
Akoya Biosciences Inc
NASDAQ:AKYA
Watchlist
Price: 1.29 USD
Market Cap: $64.4m

Operating Margin

-46.1%
Current
Improving
by 19.4%
vs 3-y average of -65.5%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-46.1%
=
Operating Income
$-36.9m
/
Revenue
$80m

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-46.1%
=
Operating Income
$-36.9m
/
Revenue
$80m

Peer Comparison

Country Company Market Cap Operating
Margin
US
Akoya Biosciences Inc
NASDAQ:AKYA
64.3m USD
Loading...
US
PerkinElmer Inc
LSE:0KHE
1.3T USD
Loading...
US
Thermo Fisher Scientific Inc
NYSE:TMO
238.2B USD
Loading...
US
Danaher Corp
NYSE:DHR
168.1B USD
Loading...
KR
Samsung Biologics Co Ltd
KRX:207940
46.3T KRW
Loading...
CH
Lonza Group AG
SIX:LONN
37.7B CHF
Loading...
US
IQVIA Holdings Inc
NYSE:IQV
40.4B USD
Loading...
CN
WuXi AppTec Co Ltd
SSE:603259
279.2B CNY
Loading...
US
Agilent Technologies Inc
NYSE:A
39.3B USD
Loading...
US
Mettler-Toledo International Inc
NYSE:MTD
29.2B USD
Loading...
FR
Sartorius Stedim Biotech SA
PAR:DIM
20.3B EUR
Loading...

Market Distribution

Lower than 81% of companies in the United States of America
Percentile
19th
Based on 14 112 companies
19th percentile
-46.1%
Low
-4 087 900% — -5.1%
Typical Range
-5.1% — 14.8%
High
14.8% — 1 032 600%
Distribution Statistics
the United States of America
Min -4 087 900%
30th Percentile -5.1%
Median 6%
70th Percentile 14.8%
Max 1 032 600%

Akoya Biosciences Inc
Glance View

Akoya Biosciences, Inc. is a life sciences technology company delivering spatial biology solutions focused on transforming discovery and clinical research. The company is headquartered in Marlborough, Massachusetts and currently employs 319 full-time employees. The company went IPO on 2021-04-16. The firm deliveries spatial biology solutions, which is focused on transforming discovery and clinical research. Spatial biology technology enables academic and biopharma scientists to detect and map the distribution of cell types and biomarkers across whole tissue samples at single-cell resolution, enabling advancements in their understanding of disease progression and patient response to therapy. Through its PhenoCycler and PhenoImager platform, reagents, software and services, it offers end-to-end solutions to perform tissue analysis and spatial phenotyping across the full continuum from discovery through translational and clinical research. The company provides PhenoImager HT, which is a digital pathology slide scanner featuring MOTiF whole-slide multispectral scanning of up to seven biomarkers with an 80-slide capacity. The company offers contract research services laboratory, which is called as advanced biopharma solutions.

AKYA Intrinsic Value
HIDDEN
Show
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
-46.1%
=
Operating Income
$-36.9m
/
Revenue
$80m
What is Akoya Biosciences Inc's current Operating Margin?

The current Operating Margin for Akoya Biosciences Inc is -46.1%, which is above its 3-year median of -65.5%.

How has Operating Margin changed over time?

Over the last 3 years, Akoya Biosciences Inc’s Operating Margin has increased from -78.8% to -46.1%. During this period, it reached a low of -93.6% on Sep 30, 2022 and a high of -46.1% on May 1, 2025.

Back to Top